1. 1) 日本結核病学会:結核診療ガイドライン改訂第2版.南江堂,2012;p. 134.
2. 2) World Health Organization:Guidelines for treatment of tuberculosis 4th edition. World Health Organization, 2010;p. 147.
3. 3) World Health Organization: Global action plan on antimicrobial resistance. World Health Organization, 2015;p. 28.
4. 4) 国際的に脅威となる感染症対策関係閣僚会議:薬剤耐性(AMR)対策アクションプラン National Action Plan on Antimicrobial Resistance 2016-2020.厚生労働省[Internet]. 2016.Available from : https://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000120769.pdf
5. 5) Colodner R, Kometiani I, Chazan B, Raz R: Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli. Infection. 2008;36(1):41―5.